|
Re: ZENITH at 2.00
|
1
|
Resverlogix Corp.
|
Sep 07, 2018 10:23AM
|
|
Re: Symposium at ESC in Barcelona
|
1
|
Resverlogix Corp.
|
Aug 26, 2017 11:44AM
|
|
Re: March Presentation
|
1
|
BIOASIS TECHNOLOGIES INC
|
Mar 24, 2021 05:37PM
|
|
Re: apabetalone and colorectal cancer
|
1
|
Resverlogix Corp.
|
Nov 13, 2018 09:40AM
|
|
Re: Awaken Dormant DNA, Epigenetically - Article in GEN
|
1
|
Zenith Epigenetics
|
Jan 13, 2018 11:23PM
|
|
Re: Hepalink
|
1
|
Resverlogix Corp.
|
Feb 25, 2020 01:37PM
|
|
10-41: Re: Haven't written off a potential role for Apabetalone to play yet.
|
1
|
Resverlogix Corp.
|
Apr 02, 2020 06:16PM
|
|
Re: The waiting game.....
|
1
|
Resverlogix Corp.
|
Feb 04, 2019 04:25PM
|
|
Re: Next Hurdle
|
1
|
Resverlogix Corp.
|
Jan 05, 2018 01:21PM
|
|
Resverlogix Announces Private Placement
|
1
|
Resverlogix Corp.
|
Aug 14, 2020 06:41PM
|
|
Re: Dr. Mark Day interview with Proactive Investors at BIO CEO
|
1
|
BIOASIS TECHNOLOGIES INC
|
Feb 12, 2019 12:24PM
|
|
ERA-EDTA 2018 Symposium Presentations "Epigenetics in CKD & CVD: A potential breakthrough therapy?"
|
1
|
Resverlogix Corp.
|
Dec 14, 2018 01:32PM
|
|
Re: This is sort off topic but not really.
|
1
|
Zenith Epigenetics
|
Mar 28, 2019 07:03AM
|
|
Re: The hit is starting
|
1
|
BIOASIS TECHNOLOGIES INC
|
Nov 18, 2019 10:34AM
|
|
Re: Its out on SEDAR...
|
1
|
Resverlogix Corp.
|
Nov 15, 2016 03:32PM
|
|
Re: Zenith AGM Presentation now posted on Zenith website
|
1
|
Zenith Epigenetics
|
Jan 17, 2016 09:45PM
|
|
Re: Standard of Care in BETonMACE
|
1
|
Resverlogix Corp.
|
Mar 19, 2019 10:47AM
|
|
Re: Hopefully DM's exuberance is justified in the secondary endpoints
|
1
|
Zenith Epigenetics
|
Nov 18, 2019 10:34AM
|
|
Re: … Zack’s analyst report's impact...
|
1
|
Resverlogix Corp.
|
Nov 04, 2015 03:28PM
|
|
Re: Dr. Deborah Rathjen, CEO & Managing Director of Bionomics Appointed Chair of the Bioasis Board of Directors
|
1
|
BIOASIS TECHNOLOGIES INC
|
Mar 21, 2018 09:44AM
|
